| Systematic (IUPAC) name | |
|---|---|
| chloromethyl 17-ethoxycarbonyloxy- 11-hydroxy- 10,13-dimethyl-3-oxo- 7,8,9,11,12,14,15, 16-octahydro- 6H-cyclopenta[a] phenanthrene-17-carboxylate | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a606003 |
| Pregnancy cat. | C (US) |
| Legal status | ℞-only (US) |
| Identifiers | |
| CAS number | 82034-46-6 |
| ATC code | S01BA14 |
| PubChem | CID 444025 |
| DrugBank | DB00873 |
| ChemSpider | 392049 |
| UNII | Z8CBU6KR16 |
| KEGG | D01689 |
| ChEMBL | CHEMBL1201389 |
| Chemical data | |
| Formula | C24H31ClO7 |
| Mol. mass | 466.951 g/mol |
| |
|
Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used in optometry and ophthalmology. Marketed by Bausch and Lomb as Lotemax in the U.S., ocular applications for this drug include the treatment of inflammation of the eye due to allergies (according to the prescription information sheet), as well as chronic forms of keratitis (e.g.: adenoviral and Thygeson’s keratitis), vernal keratoconjunctivitis, pingueculitis, and episcleritis. The drug has little or no effect on intraocular pressure.
Druzgala, P.; Hochhaus, G.; Bodor, N.; J. Steroid Biochem. Mol. Biol. 1991, 38, 149.
http://dx.doi.org/10.1016/0960-0760(91)90120-T
|
||||||||||||||||||||||||||||||||||||||
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Here you can share your comments or contribute with more information, content, resources or links about this topic.